Mumbai: Cipla Limited has announced the elevation of Achin Gupta,currently theGlobal Chief Operating Officer, as the company's next Managing Director (MD) andGlobal Chief Executive Officer (GCEO) effective April 1, 2026, for atenureof 5 years. The appointment will be proposed to the shareholders for their approval. He has been appointed as MD & GCEO Designate from January 1st, 2026. Achin will succeed Umang Vohra, who has served as the MD & GCEO of Cipla since 2016. Achin Gupta has been serving as the GCOO of the Company since February 2025, overseeing Commercial markets, API, Manufacturing, and Supply Chain. He joinedCiplain 2021 as the CEO of the One India business and has been an integral member of the Management Council. He has driven strong growth, expanded Cipla’s reach in chronic therapies and underserved geographies, and strengthened its core operations. Under his leadership, the India business delivered market-leading profitability, modernized its retail force, and introduced consumerfocused innovations. Achin also forged strategic global partnerships, positioning Cipla as a preferred innovation-led collaborator. Before joining Cipla, Achin held several roles atGlenmark PharmaceuticalsandAbbott Laboratories. Heholds a M Tech degree from IIT Delhi, specializing in Biochemical Engineering and Biotechnology and an MBA from IIM, Ahmedabad. In over two decades of his career, Achin has built a strong track record as an entrepreneurial leader. Achin is known for building new frontiers and fostering a culture of purpose, innovation, and accountability. Umang Vohra who joined Cipla in 2015 as Global Chief Financial & Strategy Officer and thereafter served as Cipla’s MD & GCEO since 2016.